Effects of Telerehabilitation Versus Clinical Rehabilitation on Chemotherapy Induced Peripheral N… (NCT06696976) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effects of Telerehabilitation Versus Clinical Rehabilitation on Chemotherapy Induced Peripheral Neuropathy
Pakistan66 participantsStarted 2024-11-20
Plain-language summary
The aim of this study is to determine the comparative effects of telerehabilitation versus clinical rehabilitation on neuropathic pain, physical function and quality of life in Chemotherapy induced peripheral neuropathy patients.
Who can participate
Age range45 Years – 75 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female patients with breast cancer.
* Patients of age between 45 to 75years.
* Patient expected to survive for 6 month or more.
* Patient after specific chemotherapy such as taxanes(paclitaxel),vinca alkaloids(vinorelbine),bortezomib, lenalidomide and platinum-based.
* Patient with Stage 1 to 3.
* Patients have prior history of mechanical nerve entrapment without clinical symptoms (carpal tunnel syndrome) were included.
* Patient who sustained grade 3 and 4 of European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20).
Exclusion Criteria:
* Patients with history of peripheral neuropathy.
* Participants are excluded if they had comorbid conditions causing peripheral neuropathic symptoms (including previous chemotherapy or diabetes or alcohol abuse and non-alcoholic liver diseases.
* Patients not scheduled for one of the aforementioned taxane-based regimens.
* Patients with vitamin D or B12 deficiency.
* Non-ambulatory Patients.
* Patients reluctant to practice exercise program.
* Patient have impaired visual or vestibular system and presence of bone or any kind of central nervous system involvement , including cancer.